Star Lake BioscienceZhaoqing Guangdong Toekomstige groei

Future criteriumcontroles 1/6

Star Lake BioscienceZhaoqing Guangdong zal naar verwachting groeien in winst en omzet met respectievelijk 18.1% en 3.1% per jaar. De winst per aandeel zal naar verwachting groeien met 18.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 14.4% zijn.

Belangrijke informatie

18.1%

Groei van de winst

18.1%

Groei van de winst per aandeel

Food winstgroei	22.3%
Inkomstengroei	3.1%
Toekomstig rendement op eigen vermogen	14.4%
Dekking van analisten	Low
Laatst bijgewerkt	30 Oct 2024

Recente toekomstige groei-updates

Recent updates

Why Star Lake BioscienceZhaoqing Guangdong's (SHSE:600866) Earnings Are Better Than They Seem

Nov 04

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Seems To Use Debt Quite Sensibly

Oct 27

Little Excitement Around Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Earnings

Sep 25

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Ticks All The Boxes When It Comes To Earnings Growth

Jul 26

Estimating The Intrinsic Value Of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHSE:600866)

May 28

There's No Escaping Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Muted Earnings Despite A 26% Share Price Rise

Apr 29

Winst- en omzetgroeiprognoses

SHSE:600866 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	18,479	1,356	N/A	3,210	2
12/31/2025	17,823	1,197	N/A	1,380	2
12/31/2024	17,062	1,026	N/A	2,416	2
9/30/2024	17,435	866	1,647	2,173	N/A
6/30/2024	17,594	954	1,593	2,009	N/A
3/31/2024	17,410	809	2,150	2,512	N/A
12/31/2023	17,374	678	1,650	2,026	N/A
9/30/2023	17,343	598	1,231	1,503	N/A
6/30/2023	16,932	429	1,345	1,680	N/A
3/31/2023	17,479	546	445	845	N/A
12/31/2022	17,486	608	1,210	1,663	N/A
9/30/2022	16,084	595	1,493	2,009	N/A
6/30/2022	12,294	497	181	630	N/A
3/31/2022	7,938	301	-78	312	N/A
12/31/2021	4,071	152	-182	168	N/A
9/30/2021	1,170	96	-38	171	N/A
6/30/2021	1,129	130	-123	142	N/A
3/31/2021	1,134	151	-114	210	N/A
12/31/2020	1,116	149	-40	250	N/A
9/30/2020	1,011	137	-150	159	N/A
6/30/2020	1,081	156	-104	171	N/A
3/31/2020	1,038	145	2	183	N/A
12/31/2019	1,050	150	56	213	N/A
9/30/2019	1,061	132	136	226	N/A
6/30/2019	969	103	150	181	N/A
3/31/2019	926	71	75	104	N/A
12/31/2018	859	42	17	51	N/A
9/30/2018	849	-82	-23	16	N/A
6/30/2018	852	-101	N/A	28	N/A
3/31/2018	805	-124	N/A	72	N/A
12/31/2017	687	-158	N/A	50	N/A
9/30/2017	668	-35	N/A	52	N/A
6/30/2017	634	1	N/A	34	N/A
3/31/2017	638	22	N/A	28	N/A
12/31/2016	680	24	N/A	41	N/A
9/30/2016	618	-232	N/A	11	N/A
6/30/2016	621	-333	N/A	2	N/A
3/31/2016	656	-397	N/A	-11	N/A
12/31/2015	730	-422	N/A	3	N/A
9/30/2015	882	-312	N/A	60	N/A
6/30/2015	923	-319	N/A	89	N/A
3/31/2015	912	-353	N/A	53	N/A
12/31/2014	871	-361	N/A	-20	N/A
9/30/2014	819	-163	N/A	-57	N/A
6/30/2014	817	-77	N/A	-58	N/A
3/31/2014	856	19	N/A	-81	N/A
12/31/2013	903	20	N/A	-28	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 600866 ( 18.1% per jaar) ligt boven de spaarquote ( 2.8% ).

Winst versus markt: De winst van 600866 ( 18.1% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 26.1% per jaar).

Hoge groeiwinsten: De winst van 600866 zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van 600866 ( 3.1% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 13.9% per jaar).

Hoge groei-inkomsten: De omzet van 600866 ( 3.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen 600866 zal naar verwachting over 3 jaar laag zijn ( 14.4 %).

Star Lake BioscienceZhaoqing Guangdong Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 11% to CN¥8.22

Recent updates

Why Star Lake BioscienceZhaoqing Guangdong's (SHSE:600866) Earnings Are Better Than They Seem

Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.16 in 3Q 2023)

Price target increased by 11% to CN¥8.22

Investor sentiment improves as stock rises 16%

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Seems To Use Debt Quite Sensibly

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 18%

Little Excitement Around Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Earnings

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Ticks All The Boxes When It Comes To Earnings Growth

Now 20% undervalued

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2024 Results on Aug 27, 2024

Estimating The Intrinsic Value Of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHSE:600866)

New minor risk - Share price stability

Now 23% overvalued after recent price rise

Investor sentiment improves as stock rises 28%

There's No Escaping Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Muted Earnings Despite A 26% Share Price Rise

New minor risk - Financial position

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.073 in 1Q 2023)

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, Annual General Meeting, May 13, 2024

Investor sentiment improves as stock rises 25%

Now 21% undervalued after recent price drop

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q1, 2024 Results on Apr 23, 2024

Now 21% undervalued after recent price drop

Now 23% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 19%

Now 23% undervalued after recent price drop

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Fiscal Year 2023 Results on Apr 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.053 in 3Q 2022)

New minor risk - Profit margin trend

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2023 Results on Aug 29, 2023

Full year 2022 earnings released: EPS: CN¥0.51 (vs CN¥0.14 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.053 (vs CN¥0.005 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.075 (vs CN¥0.056 in 2Q 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.005 (vs CN¥0.035 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.056 (vs CN¥0.07 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.047 (vs CN¥0.044 in 1Q 2020)

New 90-day low: CN¥3.77

New 90-day low: CN¥4.39

New 90-day high: CN¥4.95

New 90-day low: CN¥4.42

Third quarter earnings released

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q3, 2020 Results on Oct 27, 2020

New 90-day high - CN¥5.57

First half earnings released

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2020 Results on Aug 25, 2020

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven